These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Familial inducible torsade de pointes with normal QT interval. Strasberg B; Welch W; Palileo E; Swiryn S; Bauernfeind R; Rosen KM Eur Heart J; 1983 Jun; 4(6):383-90. PubMed ID: 6617684 [TBL] [Abstract][Full Text] [Related]
23. Amiodarone in patients with previous drug-mediated torsade de pointes. Long-term safety and efficacy. Mattioni TA; Zheutlin TA; Sarmiento JJ; Parker M; Lesch M; Kehoe RF Ann Intern Med; 1989 Oct; 111(7):574-80. PubMed ID: 2774388 [TBL] [Abstract][Full Text] [Related]
24. Etiology, warning signs and therapy of torsade de pointes. A study of 10 patients. Keren A; Tzivoni D; Gavish D; Levi J; Gottlieb S; Benhorin J; Stern S Circulation; 1981 Dec; 64(6):1167-74. PubMed ID: 7296791 [TBL] [Abstract][Full Text] [Related]
25. Poisoning due to class IA antiarrhythmic drugs. Quinidine, procainamide and disopyramide. Kim SY; Benowitz NL Drug Saf; 1990; 5(6):393-420. PubMed ID: 2285495 [TBL] [Abstract][Full Text] [Related]
26. [Torsade de pointes syndromes. Variations and limits]. Coumel P; Lucet V Ann Cardiol Angeiol (Paris); 1986 Apr; 35(4):205-14. PubMed ID: 3740773 [TBL] [Abstract][Full Text] [Related]
27. Quinidine syncope: torsade de pointes with low quinidine plasma concentrations. Jenzer HR; Hagemeijer F Eur J Cardiol; 1976 Dec; 4(4):447-51. PubMed ID: 63370 [TBL] [Abstract][Full Text] [Related]
29. Atypical ventricular tachycardia as a manifestation of disopyramide toxicity. Meltzer RS; Robert EW; McMorrow M; Martin RP Am J Cardiol; 1978 Dec; 42(6):1049-53. PubMed ID: 727132 [TBL] [Abstract][Full Text] [Related]
30. Thioridazine-induced torsade de pointes. Successful therapy with isoproterenol. Kemper AJ; Dunlap R; Pietro DA JAMA; 1983 Jun; 249(21):2931-4. PubMed ID: 6842807 [TBL] [Abstract][Full Text] [Related]
32. Torsade de pointes and other pause-induced ventricular tachycardias: the short-long-short sequence and early afterdepolarizations. Cranefield PF; Aronson RS Pacing Clin Electrophysiol; 1988 Jun; 11(6 Pt 1):670-8. PubMed ID: 2456546 [TBL] [Abstract][Full Text] [Related]
33. Torsade de pointes: the long-short initiating sequence and other clinical features: observations in 32 patients. Kay GN; Plumb VJ; Arciniegas JG; Henthorn RW; Waldo AL J Am Coll Cardiol; 1983 Nov; 2(5):806-17. PubMed ID: 6630761 [TBL] [Abstract][Full Text] [Related]
34. Ventricular tachycardia with torsade de pointes morphology induced by oral disopyramide. Commerford PJ; Beck W S Afr Med J; 1980 Sep; 58(11):447-8. PubMed ID: 7404173 [TBL] [Abstract][Full Text] [Related]
35. Torsades de pointes: electrophysiologic studies in patients without transient pharmacologic or metabolic abnormalities. Horowitz LN; Greenspan AM; Spielman SR; Josephson ME Circulation; 1981 May; 63(5):1120-8. PubMed ID: 7471373 [TBL] [Abstract][Full Text] [Related]